PA HB 2731: An Act amending The Administrative Code of 1929, in powers and duties of the Department of Drug and Alcohol Programs
PA HB 2731 amends the Administrative Code to expand the Department of Drug and Alcohol Programs' powers regarding generic naloxone, potentially affecting pharmacy operations related to naloxone dispensing.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 12, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Pharmacies and entities involved in dispensing or distributing generic naloxone in Pennsylvania. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the bill text.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The bill updates the Department of Drug and Alcohol Programs' powers and duties concerning generic naloxone, which may lead to new or revised regulations or programs.
Who it affects
Pharmacies and entities involved in dispensing or distributing generic naloxone in Pennsylvania.
What you must do
Monitor the Department of Drug and Alcohol Programs for any new rules or guidance regarding generic naloxone; review current naloxone dispensing procedures to ensure alignment with any upcoming changes.
Deadline
Not specified in the bill text.
Source: https://www.palegis.us/legislation/bills
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- FDA Announces Draft Guidance on Outsourcing Facility Sales - Quarles
- New Jersey Pharmacies Will Soon Be Able to Sell Birth Control Without a Prescription | Publications | Insights - Faegre Drinker
- Changes Coming For Prescribers To The Texas Prescription Drug Monitoring Program - JD Supra
- Illinois PBM Law to Limit Steering, Other Plan Design Features in 2026 - ogletree.com
- Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant from Schedule IV into Schedule V